Los Angeles Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
91,401
+36,357
+66% +$1.35M 0.01% 423
2025
Q4
$1.94M Sell
55,044
-130
-0.2% -$5.24K 0.01% 451
2025
Q3
$1.89M Buy
55,174
+25,161
+84% +$722K 0.01% 520
2025
Q2
$811K Buy
30,013
+11,531
+62% +$334K ﹤0.01% 705
2025
Q1
$548K Sell
18,482
-885
-5% -$33.7K ﹤0.01% 727
2024
Q4
$767K Sell
19,367
-1,293
-6% -$49K ﹤0.01% 702
2024
Q3
$703K Sell
20,660
-250
-1% -$7.03K ﹤0.01% 769
2024
Q2
$453K Hold
20,910
﹤0.01% 886
2024
Q1
$463K Buy
20,910
+11,303
+118% +$276K ﹤0.01% 895
2023
Q4
$264K Buy
+9,607
New +$232K ﹤0.01% 1044
2022
Q3
Sell
-26,749
Closed -$532K 1391
2022
Q2
$532K Buy
+26,749
New +$540K ﹤0.01% 944
2022
Q1
Sell
-5,948
Closed -$245K 1504
2021
Q4
$245K Sell
5,948
-57
-0.9% -$2.52K ﹤0.01% 1304
2021
Q3
$279K Buy
6,005
+130
+2% +$5.67K ﹤0.01% 1334
2021
Q2
$235K Sell
5,875
-300
-5% -$12.8K ﹤0.01% 1454
2021
Q1
$332K Buy
+6,175
New +$356K ﹤0.01% 1400
2019
Q4
Sell
-13,035
Closed -$313K 1352
2019
Q3
$313K Buy
13,035
+1,500
+13% +$39.9K ﹤0.01% 1114
2019
Q2
$329K Buy
11,535
+390
+3% +$9.74K ﹤0.01% 1165
2019
Q1
$279K Hold
11,145
﹤0.01% 1215
2018
Q4
$140K Buy
+11,145
New +$132K ﹤0.01% 1225

Other funds holding VCYT

Los Angeles Capital Management's VCYT Position: Q1 2026 in Review

Los Angeles Capital Management increased its Veracyte (VCYT) stake by 66% in Q1 2026, buying an estimated $1.35M and bringing the position to 91,401 shares worth $2.94M. The position accounts for 0.01% of the portfolio, ranked #423.

Los Angeles Capital Management first reported a position in VCYT in Q4 2018 and has held it in 19 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Los Angeles Capital Management held 91,401 shares of Veracyte worth $2.94M as of Q1 2026.
  • Los Angeles Capital Management bought 36,357 Veracyte shares in Q1 2026, an estimated $1.35M.
  • Veracyte made up 0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #423 holding.
  • Los Angeles Capital Management first reported a position in Veracyte in Q4 2018 and has held it in 19 quarters since.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.